Neurogene Inc. (NGNE)
16.34
-1.35 (-7.63%)
At close: Mar 03, 2025, 3:59 PM
16.21
-0.77%
After-hours: Mar 03, 2025, 04:00 PM EST
Neurogene Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| Cash & Equivalents | 148.21M | 82.02M | 70.54M | 192.56M | 143.09M | 76.93M | 52.03M | 32.3M | 39.53M | 14.91M | 54.13M | 2M | 9.24M |
| Short-Term Investments | 48.95M | n/a | n/a | n/a | n/a | n/a | 56.05M | 70.76M | 34.96M | 24.19M | 2.82M | n/a | n/a |
| Long-Term Investments | 508K | n/a | 878K | n/a | n/a | n/a | n/a | 50.05M | 38.46M | 2M | n/a | n/a | n/a |
| Other Long-Term Assets | 764K | 87K | -878K | 2.27M | 597K | 53K | 599K | -1 | 1.00 | 13.39K | 1.59M | 34.84K | 30.14K |
| Receivables | 600K | 990K | n/a | n/a | n/a | n/a | n/a | n/a | 32K | 65.45K | 27.95K | 28.55K | 219.55K |
| Inventory | n/a | 1.08M | 1.91M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | 2.59M | 1.71M | 3.41M | 1.97M | 503K | 237K | 740K | 426K | 282K | 139.01K | 63.98K | 35K | 27.63K |
| Total Current Assets | 200.35M | 84.72M | 73.96M | 194.52M | 143.6M | 77.17M | 108.83M | 103.48M | 74.8M | 39.3M | 57.04M | 2.06M | 9.49M |
| Property-Plant & Equipment | 20.95M | 24.46M | 27.53M | 13.72M | 2.83M | 400K | 905K | 849K | 89K | 104.69K | 75.47K | 157.8K | 259.38K |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 62.51K | 85.26K | 108.02K |
| Total Long-Term Assets | 22.23M | 24.55M | 27.53M | 16M | 3.43M | 453K | 1.5M | 50.89M | 38.55M | 2.12M | 1.73M | 277.91K | 397.54K |
| Total Assets | 222.57M | 109.27M | 101.49M | 210.52M | 147.02M | 77.62M | 110.33M | 154.38M | 113.34M | 41.42M | 58.77M | 2.34M | 9.88M |
| Account Payables | 2.6M | 625K | 5.63M | 1.32M | 1.6M | 702K | n/a | n/a | n/a | 734.19K | 599.83K | 188.54K | 317.5K |
| Deferred Revenue | n/a | 5.16M | 4.35M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Short-Term Debt | 2.88M | 702K | 610K | 708K | 618K | n/a | n/a | n/a | n/a | n/a | 250K | n/a | n/a |
| Other Current Liabilities | 17.5M | 5.32M | 4.62M | 5.86M | 2.52M | 3.92M | 10.96M | 9.52M | 4.79M | 4.47M | 1.77M | 196.85K | 290.39K |
| Total Current Liabilities | 22.97M | 6.65M | 10.86M | 7.89M | 4.74M | 4.63M | 10.96M | 9.52M | 4.79M | 5.2M | 2.62M | 385.39K | 607.89K |
| Long-Term Debt | 13.37M | 3.99M | 4.6M | 11.41M | 593K | 6K | 33K | 47K | 131K | 72.34K | 2.04M | n/a | n/a |
| Other Long-Term Liabilities | 203K | 244.37M | 177.91M | n/a | n/a | -1 | 1.00 | -1 | n/a | -1 | 2.83M | 1.08M | 689.65K |
| Total Long-Term Liabilities | 13.58M | 248.35M | 182.51M | 11.41M | 593K | 319K | 486K | 197K | 131K | 72.34K | 4.86M | 1.08M | 689.65K |
| Total Liabilities | 36.55M | 255M | 193.36M | 19.3M | 5.34M | 4.95M | 11.44M | 9.72M | 4.92M | 5.28M | 7.48M | 1.47M | 1.3M |
| Total Debt | 16.25M | 4.69M | 5.21M | 12.12M | 1.21M | 6K | 33K | 47K | 131K | 72.34K | 2.29M | n/a | n/a |
| Common Stock | n/a | 1K | 1K | n/a | n/a | n/a | n/a | n/a | n/a | 11.00 | 10.00 | 534.77K | 534.77K |
| Retained Earnings | -187.15M | -150.84M | -95.65M | -332.81M | -299.53M | -230.09M | -198.5M | -148.28M | -111.28M | -89.42M | -63.63M | -51.64M | -39.85M |
| Comprehensive Income | n/a | -0.00 | -0.00 | n/a | n/a | n/a | -70K | -169K | -290K | -3.85K | n/a | n/a | n/a |
| Shareholders Equity | 186.02M | -145.74M | -91.88M | 191.22M | 141.69M | 72.67M | 98.89M | 144.66M | 108.42M | 36.15M | 51.28M | 874.03K | 8.59M |
| Total Investments | 49.45M | n/a | 878K | n/a | n/a | n/a | 56.05M | 120.8M | 73.41M | 26.19M | 2.82M | n/a | n/a |